Want to see IN:KIMS full AI Analyst Report?
Krishna Institute of Medical Sciences Limited (KIMS) Stock Statistics & Valuation Metrics
Total Valuation
Krishna Institute of Medical Sciences Limited has a market cap or net worth of INR 294.80B. The enterprise value is INR 293.76B.
- Market Cap
- INR 294.80B
- Enterprise Value
- INR 293.76B
Share Statistics
Krishna Institute of Medical Sciences Limited has 420,006,470 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 420,006,470
- Owned by Insiders
- ―
- Owned by Institutions
- 5.56%
Financial Efficiency
Krishna Institute of Medical Sciences Limited’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 5.27%.
- Return on Equity (ROE)
- 0.11
- Return on Assets (ROA)
- 0.03
- Return on Invested Capital (ROIC)
- 5.27%
- Return on Capital Employed (ROCE)
- 0.08
- Revenue Per Employee
- 7.79M
- Profits Per Employee
- 481.55K
- Employee Count
- 5,013
- Asset Turnover
- 0.50
- Inventory Turnover
- 18.31
Valuation Ratios
The current PE Ratio of Krishna Institute of Medical Sciences Limited is 142.75. Krishna Institute of Medical Sciences Limited’s PEG ratio is -3.08.
- PE Ratio
- 142.75
- PS Ratio
- 7.19
- PB Ratio
- 13.47
- Price to FCF
- -64.60
- Price to Operating Cash Flow
- 106.39
- PEG Ratio
- -3.08
Income Statement
In the last 12 months, Krishna Institute of Medical Sciences Limited had revenue of 39.05B and earned 2.41B in profits. Earnings per share was 6.03.
- Revenue
- 39.05B
- Gross Profit
- 21.31B
- Operating Income
- 5.19B
- Pretax Income
- 3.34B
- Net Income
- 2.41B
- EBITDA
- 8.20B
- Earnings Per Share (EPS)
- 6.03
Cash Flow
In the last 12 months, operating cash flow was 2.85B and capital expenditures -7.53B, giving a free cash flow of -4.69B billion.
- Operating Cash Flow
- 2.85B
- Free Cash Flow
- -4.69B
- Free Cash Flow per Share
- -11.16
Dividends & Yields
Krishna Institute of Medical Sciences Limited pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -1.55%
- Earnings Yield
- 0.67%
Stock Price Statistics
- Beta
- 0.80
- 52-Week Price Change
- -0.08%
- 50-Day Moving Average
- 737.92
- 200-Day Moving Average
- 730.20
- Relative Strength Index (RSI)
- 53.93
- Average Volume (3m)
- 106.82K
Important Dates
Krishna Institute of Medical Sciences Limited upcoming earnings date is Nov 04, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 03, 2026
- Next Earnings Date
- Nov 04, 2026
- Ex-Dividend Date
- ―
Financial Position
Krishna Institute of Medical Sciences Limited as a current ratio of 0.76, with Debt / Equity ratio of 189.24%
- Current Ratio
- 0.76
- Quick Ratio
- 0.68
- Debt to Market Cap
- 0.13
- Net Debt to EBITDA
- 5.10
- Interest Coverage Ratio
- 2.56
Taxes
In the past 12 months, Krishna Institute of Medical Sciences Limited has paid 919.00M in taxes.
- Income Tax
- 919.00M
- Effective Tax Rate
- 0.28
Enterprise Valuation
Krishna Institute of Medical Sciences Limited EV to EBITDA ratio is 40.03, with an EV/FCF ratio of -73.51.
- EV to Sales
- 8.18
- EV to EBITDA
- 40.03
- EV to Free Cash Flow
- -73.51
- EV to Operating Cash Flow
- 121.07
Balance Sheet
Krishna Institute of Medical Sciences Limited has INR 1.74B in cash and marketable securities with INR 31.87B in debt, giving a net cash position of -INR 30.13B billion.
- Cash & Marketable Securities
- INR 1.74B
- Total Debt
- INR 31.87B
- Net Cash
- -INR 30.13B
- Net Cash Per Share
- -INR 71.73
- Tangible Book Value Per Share
- INR 54.39
Margins
Gross margin is 65.63%, with operating margin of 11.92%, and net profit margin of 4.85%.
- Gross Margin
- 65.63%
- Operating Margin
- 11.92%
- Pretax Margin
- 6.57%
- Net Profit Margin
- 4.85%
- EBITDA Margin
- 20.43%
- EBIT Margin
- 12.58%
Analyst Forecast
The average price target for Krishna Institute of Medical Sciences Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 30.90%
- EPS Growth Forecast
- -46.26%
Scores
- Smart Score
- ―
- AI Score
- 52
